Reuters logo
BRIEF-Galapagos says first clinical centers opened for phase 2 crohn's study with glpg0634
January 29, 2014 / 3:35 PM / 4 years ago

BRIEF-Galapagos says first clinical centers opened for phase 2 crohn's study with glpg0634

Brussels, Jan 29 (Reuters) - Galapagos NV : * Says first clinical centers opened for phase 2 crohn’s study with glpg0634 * Says first selective jak1 inhibitor to enter phase 2 in crohn’s disease * Says phase 2 study will evaluate the efficacy and safety of glpg0634

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below